A Patient Questionnaire for Radiation-Induced Brachial Plexopathy
Ki-67 Proliferation Index
Docetaxel Versus Paclitaxel for Adjuvant Treatment of Ovarian Cancer
Phase II Trial of Vinorelbine Plus Doxorubicin in Relapsed Small-Cell Lung Cancer
Effects of Carbon-Ion Beams on Human Pancreatic Cancer Cell Lines That Differ in Genetic Status
Sinonasal Teratocarcinosarcoma
Temozolomide in Combination With Irinotecan for Treatment of Recurrent Malignant Glioma
Simultaneous Mutations in K-ras and TP53 Are Indicative of Poor Prognosis in Sporadic Colorectal Cancer
Paclitaxel and Carboplatin as Second-Line Therapy in Women With Platinum-Sensitive Ovarian Carcinoma Treated With Platinum and Paclitaxel as First-Line Therapy
Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12
Adjuvant Cytotoxic and Endocrine Therapy in Pre- and Postmenopausal Patients With Breast Cancer and One to Nine Infiltrated Nodes
Multimodality Therapy for Thymic Carcinoma (TCA)
Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease
Potential Drug Interaction With Paclitaxel and Highly Active Antiretroviral Therapy in Two Patients With AIDS-Associated Kaposi Sarcoma
Pattern of Proliferative Index (Ki-67) After Anti-Androgen Manipulation Reflects the Ability of Irradiation to Control Prostate Cancer
Phase I Study With Dose Escalation of Gemcitabine and Cisplatin in Combination With Ifosfamide (GIP) in Patients With Non–Small-Cell Lung Carcinoma
Squamous Cell Carcinoma Arising in a Second Branchial Cleft Cyst
5-Fluorouracil Administered as a 48-Hour Semiintermittent Infusion in Combination With Leucovorin, Cisplatin and Epirubicin
Cancer Management Controversy: On Residency Training